2018 American Transplant Congress
The Financial Impact of the Opioid Epidemic on Kidney Transplantation Readmissions
Research has demonstrated increased annual medical costs in patients who abuse opioids, estimated at up to $18,000 per patient and $29 billion overall in the…2018 American Transplant Congress
Analysis of Cost Effectiveness of Treatment for Acute Antibody-Mediated Rejection
Tulane University School of Medicine, New Orleans, LA.
Purpose: Because AMR can be a risk factor for graft loss, the expense created by AMR treatment may be subject to scrutiny in patients who…2018 American Transplant Congress
Economic Evaluation of Contemporary Kidney Transplant Practice
Kidney transplantation (KTx) has been established as the optimal therapy for medically suitable patients with end-stage renal disease, prolonging survival and reducing health care spending.…2018 American Transplant Congress
Cost Analysis of Biliary Strictures Following Orthotopic Liver Transplantation in the United States
Introduction: While previous studies have evaluated risk factors, management, and outcomes in patients who develop biliary strictures (BS) after undergoing orthotopic liver transplantation (OLT), none…2018 American Transplant Congress
Cost Effectiveness of Hepatitis C Positive Donor Kidney Transplantation for Hepatitis C Negative Recipients with Concomitant Direct-Acting Anti-Viral Therapy
Virginia Commonwealth University, Richmond.
Background: The development of direct acting antiviral (DAA) therapy for hepatitis C virus (HCV) could allow for safe and effective treatment following renal transplantation (RT).…2018 American Transplant Congress
Comparative Cost Analysis of ABO-Incompatible Living Kidney Transplantation
BackgroundABO-incompatible living kidney transplantation (ABO-I) has been accepted as a valid alternative therapy for patients with end-stage kidney disease. The number of ABO-I has been…2018 American Transplant Congress
Deceased Donor Initiated Kidney Transplant Exchanges and the Forgotten Incompatible Directed Donor Recipients
Although incompatibility is usually viewed as affecting potential recipients of live donors, it is also encountered in instances of directed donation of deceased donors. In…2018 American Transplant Congress
Evaluation and Cost Burden of Inappropriately Drawn Immunosuppression Trough Levels in the Acute Care Setting at an Academic Medical Center
University of Virginia Health System, Charlottesville, VA.
Trough drug levels in narrow therapeutic index medications, such as CNI and mTOR inhibitors are used to estimate total drug exposure. Inappropriately measured trough levels…2018 American Transplant Congress
Variation in Cost of Death and Graft Failure across All Solid Organs
1St. Louis Univ, St. Louis, MO; 2SRTR, Minneapolis, MN; 3Lahey Hosp & Med Ctr, Burlington, VT.
Medicare costs for transplant vary considerably by organ, and costs in the second posttransplant year (Y2) are lower than in the first (Y1). Variability in…2018 American Transplant Congress
Overcoming Barriers to Transplant: An A2 to B Program Need Not Be Difficult, Expensive, or Time Consuming Even for Large Centers
Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC.
Introduction. Since the implementation of the new Kidney Allocation System (KAS) few centers have implemented the use of A2 donor kidneys into B recipients. Centers…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 19
- Next Page »